Study of Long-Term Viral Brain Infections
Part of Brain & nervous system, Infections clinical trials.
This study follows patients with chronic viral infections affecting the brain and spinal cord. Researchers will collect spinal fluid samples and track your health over one year to better understand these infections and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years or older
- You have a confirmed chronic viral infection of the central nervous system (brain or spinal cord)
- Your diagnosis has been confirmed by two independent neurologists at Peking Union Medical College Hospital
- You can have a lumbar puncture (spinal tap) to collect cerebrospinal fluid safely
- You are able to complete follow-up visits for at least one year
- Your viral infection explains your current symptoms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with suspected or confirmed progressive multifocal leukoencephalopathy (PML), people at higher risk, and healthy volunteers. It uses visits, brain imaging (MRI), and stored biological samples to better understand how PML progresses and who is at risk.
This trial tests if pembrolizumab, an immunotherapy drug, can help fight a rare brain virus called PML in people whose immune systems are weakened but not due to HIV. The goal is to see if it improves recovery.
This pilot study tests an IV medicine called brincidofovir for people with PML, a serious brain infection. The goal is to see if it can stop the virus from causing more damage.
This Phase 1 study tests a small drug (called an anti–CD8+ T cell minibody) to see how much reaches the brain. It may help researchers understand how to deliver similar treatments for multiple sclerosis, progressive multifocal leukoencephalopathy (PML), or other brain inflammation when the brain’s protective barrier is “open.”
This trial tests a T-cell therapy for people with PML, a rare brain infection. It aims to boost your immune system to fight the virus causing PML. You may be eligible if you have PML not caused by HIV, natalizumab, or certain recent treatments.
This study looks at how infections or inflammation involving the brain and spinal cord work, using patient data and samples. It may help researchers better understand these illnesses and improve future care.
Hear when a new Progressive Multifocal Leukoencephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.